Skip to main content
Study

Prescribing errors with low-molecular-weight heparins.

Slikkerveer M, van de Plas A, Driessen JHM, et al. Prescribing errors with low-molecular-weight heparins. J Patient Saf. 2021;17(7):e587-e592. doi: 10.1097/pts.0000000000000417.

Save

Print

October 13, 2021
Slikkerveer M, van de Plas A, Driessen JHM, et al. J Patient Saf. 2021;17(7):e587-e592.

Anticoagulants, such as low-molecular-weight heparin (LMWH), are known to be high-risk for adverse drug events. This cross-sectional study identified prescribing errors – primarily lack of dosage adjustment for body weight and/or renal function – among one-third of LMWH users admitted to one hospital over a five-month period.

Save

Print

Cite
Citation

Slikkerveer M, van de Plas A, Driessen JHM, et al. Prescribing errors with low-molecular-weight heparins. J Patient Saf. 2021;17(7):e587-e592. doi: 10.1097/pts.0000000000000417.